Insights On Trial Design

  1. 2023 Technology Adoption Trends And Plateaus 11/15/2023

    About 85% of industry leaders and managers have had some exposure to AI. Delve into the state of AI adoption experienced throughout 2023 and where the industry is headed concerning digital tool usage.

  2. Living With An Invisible Disease: One Woman's Journey With CF 4/22/2025

    Meet a clinical research participant who has spent her life navigating the challenges of cystic fibrosis, leading her to become an advocate, amplifying the voices of others facing similar struggles.

  3. What Is The Role Of Large Language Models In RWE Generation? 4/28/2025

    Large language models (LLMs) are generative AI models that can analyze and curate large amounts of RWD - at an unprecedented scale and speed - to generate real-world evidence (RWE).

  4. Drug-Drug Interaction Study On A Novel Cardiovascular Medication 9/17/2024

    Learn how Altasciences leveraged its expertise to design, recruit, and conduct complex DDI studies, assessing pharmacokinetic and pharmacodynamic impacts of co-administered drugs.

  5. Diffuse Large B-Cell Lymphoma- Global Clinical Trial Landscape 10/15/2024

    Explore the latest advancements in diffuse large B-cell lymphoma research, innovative therapies, and personalized care strategies shaping the future of treatment.

  6. A Guide To Patient Reimbursements And Payments 9/13/2024

    Delayed or inadequate payments can harm patient retention and site efficiency. Learn how sponsors can mitigate financial toxicity, streamline reimbursement, and ensure a positive experience for all involved.

  7. My First Forty Years At DIA 6/13/2024

    Following the simple logical flow we recommend for all Global Forum articles—What, So What, Now What—let’s delve into why DIA remains a cornerstone for professional growth and innovation in our field.

  8. Phase 2 Clinical Trials: What to Include (And What To Leave Out) 8/2/2023

    How do drug developers make decisions about what to include, and what to leave out, of a Phase 2 clinical trial? Mitchell Katz, SVP, global clinical operations at Kyowa Kirin discusses collecting competitive intelligence and forging relationships with regulators.

  9. Are Resource Constraints Impacting Your TMF Health? 8/22/2023

    Looking to quickly expand internal TMF resources with our anytime, anywhere TMF expertise? Unlock the potential to seamlessly access specialized TMF knowledge and support by viewing this presentation.

  10. Metabolic Disorders Clinical Trial Case Study 9/17/2024

    Check out this case study to learn how partnering with an accomplished contract research organization is essential in the complex and dynamic field of metabolic drug development.